Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study

PURPOSE: This multicenter, randomized, double-blind, placebo-controlled phase 2 study evaluated the efficacy and safety of TAC-302, a novel drug that restores neurite outgrowth, in patients with detrusor underactivity (DU) and overactive bladder (OAB). METHODS: After 2–4 weeks of observation, patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Masaki, Gotoh, Momokazu, Yokoyama, Osamu, Kakizaki, Hidehiro, Yamanishi, Tomonori, Yamaguchi, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617838/
https://www.ncbi.nlm.nih.gov/pubmed/36205739
http://dx.doi.org/10.1007/s00345-022-04163-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617838/
https://www.ncbi.nlm.nih.gov/pubmed/36205739
http://dx.doi.org/10.1007/s00345-022-04163-4

Ejemplares similares